Welcome Guest | Register / Login

Biotechnology Market Research Reports

Bio-technology is an ingenious fusion of bio-science and technology for unearthing possibilities in health care and farming. Although bio-technology is relatively a modern concept, it has enabled researchers look at the world of life-sciences from a different perspective; in fact, some of the traditionally held beliefs have either been proven wrong or differently established. As a consequence, the twin-world of medical and agriculture science has been able to understand and map solutions for better health care quality and agricultural produce.
Due to its in... View more
Sort By
Title Published Price Buy Now
Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market: Industry Analysis & Outlook (2018-2025)
By Koncept Analytics
PARP means poly (adenosine diphosphate [ADP] -ribose) polymerase. It is a family of 17 enzymes that combine several (poly) units of ADP-ribose in a chain (the PAR chain) and transfers them to the target proteins. This helps to restore DNA when it ...
Feb 2018 $ 800
Global Biologics Market: Size, Trends & Forecast (2018-2022)
By Daedal Research
Scope of the Report The report entitled “Global Biologics Market: Size, Trends & Forecast (2018-2022)”, provides an in-depth analysis of the global biologics market with description of mark...
Feb 2018 $ 900
5-Lipoxygenase Inhibitor (Arachidonate 5-Lipoxygenase Inhibitor) - Pipeline Insight
By Delve Insight
"5-Lipoxygenase Inhibitor (Arachidonate 5-Lipoxygenase Inhibitor) - Pipeline Insight, 2018" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "5-Lipoxygenase Inh...
Jan 2018 $ 1250
Aldose Reductase Inhibitor - Pipeline Insight
By Delve Insight
"Aldose Reductase Inhibitor - Pipeline Insight, 2018" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Aldose Reductase Inhibitor development. The report pro...
Jan 2018 $ 1250
Alpha-Amylase Inhibitor - Pipeline Insight
By Delve Insight
"Alpha-Amylase Inhibitor - Pipeline Insight, 2018" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Alpha-Amylase Inhibitor development. The report provides ...
Jan 2018 $ 1250
Amyloid Protein Blockers - Pipeline Insight
By Delve Insight
"Amyloid Protein Blockers - Pipeline Insight, 2018" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Amyloid Protein Blockers development. The report provide...
Jan 2018 $ 1250
Anaplastic Lymphoma Kinase (ALK) Inhibitor - Pipeline Insight
By Delve Insight
"Anaplastic Lymphoma Kinase (ALK) Inhibitor - Pipeline Insight, 2018" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Anaplastic Lymphoma Kinase (ALK) Inhibit...
Jan 2018 $ 1250
Angiopoietin Inhibitor - Pipeline Insight
By Delve Insight
"Angiopoietin Inhibitor - Pipeline Insight, 2018" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Angiopoietin Inhibitor development. The report provides de...
Jan 2018 $ 1250
Angiopoietin 2 (Ang-2) Inhibitor - Pipeline Insight
By Delve Insight
"Angiopoietin 2 (Ang-2) Inhibitor - Pipeline Insight, 2018" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Angiopoietin 2 (Ang-2) Inhibitor development. Th...
Jan 2018 $ 1250
Angiotensin Converting Enzyme (ACE) Inhibitor - Pipeline Insight
By Delve Insight
"Angiotensin Converting Enzyme (ACE) Inhibitor - Pipeline Insight, 2018" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Angiotensin Converting Enzyme (ACE) I...
Jan 2018 $ 1250
Angiotensin II Receptor Type 2 (AT2 Receptor) Inhibitor - Pipeline Insight
By Delve Insight
"Angiotensin II Receptor Type 2 (AT2 Receptor) Inhibitor - Pipeline Insight, 2018" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Angiotensin II Receptor Typ...
Jan 2018 $ 1250
Anti GM-CSF Antibody - Pipeline Insight
By Delve Insight
"Anti GM-CSF Antibody - Pipeline Insight, 2018" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Anti GM-CSF Antibody development. The report provides detail...
Jan 2018 $ 1250
Anti-CD152 Antibody - Pipeline Insight
By Delve Insight
"Anti-CD152 Antibody - Pipeline Insight, 2018" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Anti-CD152 Antibody development. The report provides detailed...
Jan 2018 $ 1250
Anti-CD19 Antibody - Pipeline Insight
By Delve Insight
"Anti-CD19 Antibody - Pipeline Insight, 2018" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Anti-CD19 Antibody development. The report provides detailed c...
Jan 2018 $ 1250
Anti-CD28 Antibody - Pipeline Insight
By Delve Insight
"Anti-CD28 Antibody - Pipeline Insight, 2018" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Anti-CD28 Antibody development. The report provides detailed c...
Jan 2018 $ 1250
Anti-CD33 Antibody - Pipeline Insight
By Delve Insight
"Anti-CD33 Antibody - Pipeline Insight, 2018" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Anti-CD33 Antibody development. The report provides detailed c...
Jan 2018 $ 1250
Anti-CD37 Antibody - Pipeline Insight
By Delve Insight
"Anti-CD37 Antibody - Pipeline Insight, 2018" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Anti-CD37 Antibody development. The report provides detailed c...
Jan 2018 $ 1250
Anti-CD38 Antibody - Pipeline Insight
By Delve Insight
"Anti-CD38 Antibody - Pipeline Insight, 2018" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Anti-CD38 Antibody development. The report provides detailed c...
Jan 2018 $ 1250
Anti-CD40 Antibody - Pipeline Insight
By Delve Insight
"Anti-CD40 Antibody - Pipeline Insight, 2018" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Anti-CD40 Antibody development. The report provides detailed c...
Jan 2018 $ 1250
Anti-CD52 Antibody - Pipeline Insight
By Delve Insight
"Anti-CD52 Antibody - Pipeline Insight, 2018" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Anti-CD52 Antibody development. The report provides detailed c...
Jan 2018 $ 1250
Anti-CD80 Antibody - Pipeline Insight
By Delve Insight
"Anti-CD80 Antibody - Pipeline Insight, 2018" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Anti-CD80 Antibody development. The report provides detailed c...
Jan 2018 $ 1250
Anti-Dickkopf-1 (Dkk-1) Antibody - Pipeline Insight
By Delve Insight
"Anti-Dickkopf-1 (Dkk-1) Antibody - Pipeline Insight, 2018" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Anti-Dickkopf-1 (Dkk-1) Antibody development. Th...
Jan 2018 $ 1250
Anti-Lymphotoxin - Pipeline Insight
By Delve Insight
"Anti-Lymphotoxin - Pipeline Insight, 2018" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Anti-Lymphotoxin development. The report provides detailed cover...
Jan 2018 $ 1250
Anti-Mucin 1 (MUC1) Antibody - Pipeline Insight
By Delve Insight
"Anti-Mucin 1 (MUC1) Antibody - Pipeline Insight, 2018" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Anti-Mucin 1 (MUC1) Antibody development. The report...
Jan 2018 $ 1250
Apolipoprotein B (ApoB) Inhibitor - Pipeline Insight
By Delve Insight
"Apolipoprotein B (ApoB) Inhibitor - Pipeline Insight, 2018" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Apolipoprotein B (ApoB) Inhibitor development. ...
Jan 2018 $ 1250